Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Clinical Trials as Topic | 31 | 2023 | 7914 | 4.180 |
Why?
|
Drug Approval | 13 | 2023 | 742 | 3.320 |
Why?
|
National Institutes of Health (U.S.) | 6 | 2023 | 780 | 2.850 |
Why?
|
United States Food and Drug Administration | 16 | 2023 | 1584 | 2.840 |
Why?
|
Legislation, Drug | 4 | 2023 | 206 | 2.270 |
Why?
|
Device Approval | 3 | 2023 | 163 | 1.940 |
Why?
|
Pediatrics | 14 | 2021 | 3475 | 1.810 |
Why?
|
Rare Diseases | 5 | 2019 | 553 | 1.810 |
Why?
|
Drug Prescriptions | 5 | 2023 | 1637 | 1.630 |
Why?
|
Research Support as Topic | 9 | 2020 | 705 | 1.590 |
Why?
|
Research Design | 14 | 2023 | 5984 | 1.570 |
Why?
|
Publishing | 7 | 2021 | 833 | 1.510 |
Why?
|
Product Surveillance, Postmarketing | 4 | 2023 | 430 | 1.500 |
Why?
|
Information Dissemination | 6 | 2023 | 1099 | 1.470 |
Why?
|
Patient Selection | 6 | 2023 | 4216 | 1.450 |
Why?
|
Child | 74 | 2024 | 77709 | 1.350 |
Why?
|
Drug Industry | 9 | 2020 | 746 | 1.340 |
Why?
|
Research | 3 | 2021 | 1999 | 1.270 |
Why?
|
Randomized Controlled Trials as Topic | 10 | 2020 | 9955 | 1.220 |
Why?
|
Emergency Service, Hospital | 22 | 2023 | 7658 | 1.200 |
Why?
|
Neuraminidase | 3 | 2016 | 210 | 1.140 |
Why?
|
Drug Utilization | 4 | 2019 | 1183 | 1.130 |
Why?
|
Hospitals, Pediatric | 10 | 2022 | 1775 | 1.030 |
Why?
|
United States | 55 | 2023 | 69872 | 1.030 |
Why?
|
Cost of Illness | 6 | 2021 | 1860 | 1.020 |
Why?
|
Pharmaceutical Preparations | 4 | 2022 | 1070 | 1.020 |
Why?
|
Drug Labeling | 5 | 2020 | 233 | 0.980 |
Why?
|
Research Subjects | 2 | 2017 | 239 | 0.950 |
Why?
|
Anticonvulsants | 3 | 2022 | 1916 | 0.940 |
Why?
|
Pharyngitis | 2 | 2022 | 215 | 0.930 |
Why?
|
Durable Medical Equipment | 1 | 2023 | 22 | 0.920 |
Why?
|
Biopharmaceutics | 1 | 2022 | 22 | 0.880 |
Why?
|
Conflict of Interest | 4 | 2018 | 544 | 0.870 |
Why?
|
Research Report | 4 | 2020 | 355 | 0.850 |
Why?
|
Adolescent | 49 | 2024 | 85779 | 0.820 |
Why?
|
Analgesics, Opioid | 8 | 2023 | 3677 | 0.810 |
Why?
|
Off-Label Use | 2 | 2020 | 169 | 0.780 |
Why?
|
Financial Support | 1 | 2021 | 115 | 0.780 |
Why?
|
Biomedical Research | 8 | 2020 | 3309 | 0.770 |
Why?
|
Streptococcal Infections | 2 | 2022 | 638 | 0.770 |
Why?
|
Drug Information Services | 2 | 2018 | 51 | 0.750 |
Why?
|
Control Groups | 1 | 2020 | 105 | 0.750 |
Why?
|
Orphan Drug Production | 2 | 2018 | 50 | 0.740 |
Why?
|
Hospitalization | 9 | 2022 | 10259 | 0.720 |
Why?
|
European Union | 4 | 2023 | 158 | 0.710 |
Why?
|
Financing, Government | 2 | 2022 | 468 | 0.710 |
Why?
|
Information Storage and Retrieval | 3 | 2020 | 824 | 0.710 |
Why?
|
Scientific Misconduct | 1 | 2020 | 71 | 0.700 |
Why?
|
Humans | 124 | 2024 | 744366 | 0.690 |
Why?
|
Databases as Topic | 2 | 2020 | 475 | 0.690 |
Why?
|
Selection Bias | 2 | 2019 | 371 | 0.680 |
Why?
|
Benzodiazepines | 2 | 2023 | 1101 | 0.680 |
Why?
|
Ambulatory Care | 3 | 2019 | 2708 | 0.680 |
Why?
|
Bronchiolitis | 2 | 2023 | 458 | 0.670 |
Why?
|
Influenza, Human | 5 | 2014 | 1479 | 0.670 |
Why?
|
Cross-Sectional Studies | 23 | 2024 | 25039 | 0.660 |
Why?
|
Acetaminophen | 2 | 2021 | 545 | 0.650 |
Why?
|
Registries | 15 | 2023 | 8091 | 0.650 |
Why?
|
Neglected Diseases | 1 | 2019 | 64 | 0.640 |
Why?
|
Respiratory Tract Infections | 2 | 2021 | 961 | 0.640 |
Why?
|
Emergency Treatment | 2 | 2015 | 517 | 0.620 |
Why?
|
Child, Preschool | 32 | 2021 | 41005 | 0.610 |
Why?
|
Review Literature as Topic | 3 | 2016 | 336 | 0.610 |
Why?
|
Authorship | 2 | 2019 | 271 | 0.590 |
Why?
|
PubMed | 3 | 2022 | 123 | 0.580 |
Why?
|
Access to Information | 1 | 2020 | 320 | 0.580 |
Why?
|
Neoplasms | 6 | 2023 | 21696 | 0.580 |
Why?
|
Drug and Narcotic Control | 1 | 2018 | 146 | 0.570 |
Why?
|
Publication Bias | 3 | 2021 | 162 | 0.570 |
Why?
|
Early Termination of Clinical Trials | 1 | 2016 | 68 | 0.560 |
Why?
|
Health Care Surveys | 6 | 2019 | 2453 | 0.550 |
Why?
|
Analgesics | 3 | 2021 | 1040 | 0.550 |
Why?
|
Enzyme Inhibitors | 3 | 2016 | 3799 | 0.550 |
Why?
|
Placebos | 1 | 2020 | 1676 | 0.540 |
Why?
|
Infant | 29 | 2021 | 35134 | 0.540 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2019 | 366 | 0.530 |
Why?
|
Minority Groups | 1 | 2023 | 1221 | 0.530 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2017 | 214 | 0.530 |
Why?
|
Government Regulation | 1 | 2019 | 522 | 0.510 |
Why?
|
Cardiovascular System | 1 | 2022 | 831 | 0.500 |
Why?
|
Developing Countries | 4 | 2020 | 2815 | 0.500 |
Why?
|
Publications | 4 | 2023 | 195 | 0.470 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2023 | 1186 | 0.470 |
Why?
|
Pandemics | 8 | 2024 | 8385 | 0.470 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2023 | 1391 | 0.460 |
Why?
|
Epilepsy | 2 | 2022 | 3310 | 0.450 |
Why?
|
Neuropsychiatry | 1 | 2013 | 55 | 0.450 |
Why?
|
Databases, Bibliographic | 3 | 2018 | 128 | 0.450 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2017 | 789 | 0.430 |
Why?
|
Age Factors | 12 | 2020 | 18373 | 0.430 |
Why?
|
Periodicals as Topic | 4 | 2019 | 1431 | 0.420 |
Why?
|
Empirical Research | 1 | 2012 | 120 | 0.400 |
Why?
|
Drug Costs | 1 | 2019 | 1105 | 0.390 |
Why?
|
Retrospective Studies | 25 | 2024 | 77460 | 0.390 |
Why?
|
Drug Interactions | 1 | 2016 | 1460 | 0.380 |
Why?
|
Developed Countries | 1 | 2013 | 437 | 0.380 |
Why?
|
Prescription Drugs | 2 | 2019 | 595 | 0.380 |
Why?
|
Infant, Newborn | 15 | 2021 | 25628 | 0.380 |
Why?
|
Drug Therapy | 1 | 2013 | 497 | 0.370 |
Why?
|
Medical Informatics | 1 | 2018 | 745 | 0.370 |
Why?
|
Mental Health | 2 | 2024 | 3010 | 0.370 |
Why?
|
Program Development | 1 | 2017 | 1316 | 0.370 |
Why?
|
Young Adult | 16 | 2024 | 56429 | 0.360 |
Why?
|
Drugs, Investigational | 1 | 2012 | 214 | 0.360 |
Why?
|
Medical Order Entry Systems | 1 | 2016 | 545 | 0.360 |
Why?
|
Endovascular Procedures | 1 | 2023 | 1980 | 0.360 |
Why?
|
Internet | 4 | 2014 | 3056 | 0.360 |
Why?
|
Comparative Effectiveness Research | 2 | 2012 | 680 | 0.350 |
Why?
|
Hypoglycemic Agents | 3 | 2020 | 2873 | 0.350 |
Why?
|
Emergency Medical Services | 2 | 2023 | 1917 | 0.340 |
Why?
|
Drug Evaluation | 1 | 2010 | 647 | 0.330 |
Why?
|
Papillomavirus Infections | 1 | 2020 | 1587 | 0.330 |
Why?
|
Long QT Syndrome | 1 | 2013 | 453 | 0.330 |
Why?
|
Patient Admission | 2 | 2014 | 1380 | 0.320 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2021 | 11726 | 0.310 |
Why?
|
Equipment Safety | 2 | 2022 | 263 | 0.310 |
Why?
|
Polypharmacy | 1 | 2010 | 294 | 0.310 |
Why?
|
Respiratory Syncytial Virus Infections | 2 | 2009 | 329 | 0.310 |
Why?
|
Population Surveillance | 3 | 2007 | 2616 | 0.300 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2009 | 139 | 0.300 |
Why?
|
Patient Access to Records | 1 | 2008 | 118 | 0.290 |
Why?
|
Crowding | 1 | 2008 | 145 | 0.290 |
Why?
|
Male | 41 | 2024 | 350115 | 0.290 |
Why?
|
Female | 42 | 2024 | 380193 | 0.280 |
Why?
|
Drug Discovery | 1 | 2014 | 1058 | 0.280 |
Why?
|
Myocardial Ischemia | 1 | 2017 | 2148 | 0.270 |
Why?
|
Outpatients | 4 | 2024 | 1487 | 0.270 |
Why?
|
Central Nervous System Stimulants | 1 | 2014 | 1148 | 0.270 |
Why?
|
Patient Dropouts | 1 | 2008 | 420 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3135 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3242 | 0.260 |
Why?
|
Medical Oncology | 3 | 2023 | 2267 | 0.260 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2064 | 0.250 |
Why?
|
Respiratory Protective Devices | 2 | 2021 | 45 | 0.250 |
Why?
|
Electronic Health Records | 1 | 2021 | 4468 | 0.240 |
Why?
|
Marketing | 2 | 2018 | 212 | 0.240 |
Why?
|
Time Factors | 5 | 2019 | 40075 | 0.240 |
Why?
|
Antineoplastic Agents | 3 | 2022 | 13693 | 0.220 |
Why?
|
Endoleak | 1 | 2023 | 106 | 0.220 |
Why?
|
Disclosure | 2 | 2020 | 736 | 0.220 |
Why?
|
Nervous System Diseases | 2 | 2013 | 1622 | 0.220 |
Why?
|
Automation | 3 | 2023 | 584 | 0.220 |
Why?
|
Hospitals, General | 1 | 2007 | 749 | 0.210 |
Why?
|
Antiviral Agents | 1 | 2014 | 2987 | 0.210 |
Why?
|
Quality Indicators, Health Care | 1 | 2012 | 1831 | 0.200 |
Why?
|
Adult | 22 | 2024 | 214052 | 0.200 |
Why?
|
Disease | 1 | 2007 | 680 | 0.200 |
Why?
|
Medical Records Systems, Computerized | 1 | 2008 | 1205 | 0.200 |
Why?
|
Anti-Bacterial Agents | 5 | 2022 | 7182 | 0.190 |
Why?
|
Minors | 1 | 2020 | 50 | 0.180 |
Why?
|
Cellulitis | 1 | 2002 | 206 | 0.180 |
Why?
|
Manuscripts as Topic | 1 | 2019 | 15 | 0.180 |
Why?
|
Streptococcus agalactiae | 1 | 2002 | 375 | 0.180 |
Why?
|
Sterilization | 1 | 2021 | 133 | 0.180 |
Why?
|
Streptococcus pyogenes | 1 | 2022 | 289 | 0.180 |
Why?
|
Editorial Policies | 2 | 2018 | 451 | 0.180 |
Why?
|
Fraud | 1 | 2020 | 67 | 0.170 |
Why?
|
Systems Analysis | 1 | 2020 | 172 | 0.170 |
Why?
|
Antipsychotic Agents | 1 | 2013 | 3057 | 0.170 |
Why?
|
Databases, Factual | 5 | 2021 | 7730 | 0.170 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2020 | 323 | 0.170 |
Why?
|
Leishmaniasis | 1 | 2019 | 47 | 0.170 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 3658 | 0.160 |
Why?
|
Rabies | 1 | 2019 | 61 | 0.160 |
Why?
|
Blood Vessel Prosthesis | 1 | 2023 | 934 | 0.160 |
Why?
|
Wounds and Injuries | 3 | 2019 | 2400 | 0.160 |
Why?
|
Hypolipidemic Agents | 2 | 2013 | 604 | 0.160 |
Why?
|
Logistic Models | 5 | 2019 | 13409 | 0.160 |
Why?
|
Industry | 1 | 2020 | 365 | 0.150 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2020 | 629 | 0.150 |
Why?
|
Orchitis | 1 | 2017 | 35 | 0.150 |
Why?
|
Epididymitis | 1 | 2017 | 37 | 0.150 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2022 | 602 | 0.150 |
Why?
|
Hydrogen Peroxide | 1 | 2021 | 730 | 0.150 |
Why?
|
Spermatic Cord Torsion | 1 | 2017 | 73 | 0.150 |
Why?
|
Injections, Intravenous | 1 | 2019 | 1420 | 0.140 |
Why?
|
Policy | 1 | 2020 | 508 | 0.140 |
Why?
|
Prevalence | 4 | 2019 | 15221 | 0.140 |
Why?
|
Health Promotion | 1 | 2008 | 2205 | 0.130 |
Why?
|
Dengue | 1 | 2019 | 256 | 0.130 |
Why?
|
Pyridones | 1 | 2020 | 711 | 0.130 |
Why?
|
Adjuvants, Immunologic | 1 | 2020 | 1000 | 0.130 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1677 | 0.130 |
Why?
|
MEDLINE | 1 | 2015 | 125 | 0.130 |
Why?
|
Neuroblastoma | 1 | 2022 | 1226 | 0.120 |
Why?
|
Compassionate Use Trials | 1 | 2014 | 46 | 0.120 |
Why?
|
Bibliometrics | 1 | 2018 | 339 | 0.120 |
Why?
|
Databases, Genetic | 2 | 2019 | 1783 | 0.120 |
Why?
|
Benchmarking | 1 | 2020 | 1042 | 0.120 |
Why?
|
Occupational Exposure | 2 | 2021 | 1793 | 0.120 |
Why?
|
Papillomavirus Vaccines | 1 | 2020 | 491 | 0.120 |
Why?
|
Life Tables | 1 | 2013 | 370 | 0.120 |
Why?
|
Therapies, Investigational | 1 | 2014 | 112 | 0.110 |
Why?
|
Metformin | 1 | 2020 | 836 | 0.110 |
Why?
|
Hospital Charges | 1 | 2015 | 362 | 0.110 |
Why?
|
International Cooperation | 1 | 2020 | 1420 | 0.110 |
Why?
|
Poison Control Centers | 1 | 2013 | 72 | 0.110 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 3922 | 0.110 |
Why?
|
Information Seeking Behavior | 1 | 2014 | 113 | 0.110 |
Why?
|
World Health Organization | 1 | 2019 | 1318 | 0.110 |
Why?
|
Risk | 2 | 2022 | 9688 | 0.110 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1856 | 0.110 |
Why?
|
Probability | 2 | 2009 | 2506 | 0.110 |
Why?
|
Waiting Lists | 2 | 2008 | 692 | 0.110 |
Why?
|
Comorbidity | 2 | 2021 | 10388 | 0.100 |
Why?
|
Aged | 7 | 2023 | 163288 | 0.100 |
Why?
|
Acute Disease | 1 | 2021 | 7147 | 0.100 |
Why?
|
Data Collection | 2 | 2013 | 3339 | 0.100 |
Why?
|
Incidence | 3 | 2020 | 20952 | 0.100 |
Why?
|
Cohort Studies | 5 | 2023 | 40559 | 0.100 |
Why?
|
Sample Size | 1 | 2014 | 845 | 0.090 |
Why?
|
National Library of Medicine (U.S.) | 1 | 2010 | 35 | 0.090 |
Why?
|
Massachusetts | 5 | 2015 | 8662 | 0.090 |
Why?
|
Respiratory Tract Diseases | 1 | 2016 | 722 | 0.090 |
Why?
|
Evidence-Based Medicine | 2 | 2013 | 3611 | 0.090 |
Why?
|
Steroids | 1 | 2016 | 930 | 0.090 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1405 | 0.090 |
Why?
|
Pyrazoles | 1 | 2020 | 1972 | 0.090 |
Why?
|
Hypnotics and Sedatives | 1 | 2017 | 1162 | 0.090 |
Why?
|
Cause of Death | 1 | 2020 | 3582 | 0.090 |
Why?
|
Health Surveys | 1 | 2019 | 4036 | 0.090 |
Why?
|
Sweden | 1 | 2012 | 1341 | 0.090 |
Why?
|
Equipment and Supplies | 1 | 2012 | 281 | 0.080 |
Why?
|
Aged, 80 and over | 4 | 2019 | 57776 | 0.080 |
Why?
|
Operating Rooms | 1 | 2016 | 817 | 0.080 |
Why?
|
Financing, Organized | 1 | 2010 | 202 | 0.080 |
Why?
|
Fever | 1 | 2016 | 1616 | 0.080 |
Why?
|
Prospective Studies | 3 | 2023 | 53290 | 0.080 |
Why?
|
Europe | 1 | 2015 | 3338 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2725 | 0.080 |
Why?
|
Treatment Outcome | 4 | 2023 | 63107 | 0.080 |
Why?
|
Utilization Review | 1 | 2009 | 392 | 0.080 |
Why?
|
Spinal Injuries | 1 | 2011 | 301 | 0.080 |
Why?
|
Health Policy | 1 | 2020 | 2661 | 0.070 |
Why?
|
Drug Design | 1 | 2013 | 1076 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2013 | 1240 | 0.070 |
Why?
|
Intensive Care Units | 2 | 2022 | 3680 | 0.070 |
Why?
|
Odds Ratio | 1 | 2019 | 9849 | 0.070 |
Why?
|
Models, Statistical | 2 | 2021 | 5101 | 0.070 |
Why?
|
Occupational Health Services | 1 | 2008 | 154 | 0.070 |
Why?
|
Length of Stay | 2 | 2019 | 6311 | 0.070 |
Why?
|
Boston | 3 | 2016 | 9312 | 0.070 |
Why?
|
Hospitals | 2 | 2021 | 3954 | 0.070 |
Why?
|
Virus Cultivation | 1 | 2006 | 92 | 0.070 |
Why?
|
Income | 1 | 2015 | 1913 | 0.070 |
Why?
|
Trauma Centers | 1 | 2011 | 891 | 0.070 |
Why?
|
Age Distribution | 2 | 2009 | 2902 | 0.070 |
Why?
|
Mammography | 1 | 2017 | 2475 | 0.070 |
Why?
|
Craniocerebral Trauma | 1 | 2010 | 482 | 0.070 |
Why?
|
Middle Aged | 8 | 2020 | 213390 | 0.070 |
Why?
|
Decision Trees | 1 | 2007 | 506 | 0.070 |
Why?
|
Cervical Vertebrae | 1 | 2011 | 976 | 0.060 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2212 | 0.060 |
Why?
|
Genetic Testing | 1 | 2017 | 3444 | 0.060 |
Why?
|
Computer-Assisted Instruction | 1 | 2008 | 365 | 0.060 |
Why?
|
Research Personnel | 2 | 2020 | 573 | 0.060 |
Why?
|
Pain | 1 | 2019 | 4988 | 0.060 |
Why?
|
Spinal Puncture | 1 | 2006 | 281 | 0.060 |
Why?
|
Sex Distribution | 1 | 2009 | 2297 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39052 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12356 | 0.060 |
Why?
|
International Classification of Diseases | 1 | 2009 | 867 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2009 | 2971 | 0.060 |
Why?
|
Medical History Taking | 1 | 2007 | 784 | 0.060 |
Why?
|
Seasons | 2 | 2006 | 1493 | 0.060 |
Why?
|
Health Resources | 1 | 2009 | 911 | 0.060 |
Why?
|
Risk Factors | 4 | 2016 | 72296 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2015 | 3395 | 0.060 |
Why?
|
Crying | 1 | 2002 | 36 | 0.050 |
Why?
|
Viruses | 1 | 2006 | 375 | 0.050 |
Why?
|
Chronic Disease | 1 | 2017 | 9145 | 0.050 |
Why?
|
Workplace | 1 | 2008 | 836 | 0.050 |
Why?
|
Mass Screening | 1 | 2017 | 5253 | 0.050 |
Why?
|
Artificial Intelligence | 1 | 2014 | 2213 | 0.050 |
Why?
|
Hospitals, Urban | 1 | 2003 | 499 | 0.050 |
Why?
|
Equipment Reuse | 1 | 2021 | 41 | 0.050 |
Why?
|
Mental Disorders | 1 | 2021 | 6598 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5135 | 0.050 |
Why?
|
Syncope | 1 | 2003 | 429 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2015 | 4369 | 0.040 |
Why?
|
Electrocardiography | 1 | 2013 | 6442 | 0.040 |
Why?
|
Virus Diseases | 1 | 2006 | 711 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2018 | 19905 | 0.040 |
Why?
|
Child, Hospitalized | 1 | 2021 | 174 | 0.040 |
Why?
|
Syndrome | 1 | 2006 | 3252 | 0.040 |
Why?
|
Government | 1 | 2020 | 165 | 0.040 |
Why?
|
Ventilators, Mechanical | 1 | 2021 | 292 | 0.040 |
Why?
|
Masks | 1 | 2021 | 197 | 0.040 |
Why?
|
Medical Staff, Hospital | 1 | 2003 | 601 | 0.040 |
Why?
|
Ethics Committees, Research | 1 | 2019 | 194 | 0.040 |
Why?
|
Trauma Severity Indices | 1 | 2019 | 481 | 0.040 |
Why?
|
Academies and Institutes | 1 | 2020 | 317 | 0.040 |
Why?
|
Poverty | 2 | 2020 | 2660 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2008 | 2278 | 0.040 |
Why?
|
Medical Records | 1 | 2003 | 1413 | 0.040 |
Why?
|
Epidemiologic Research Design | 1 | 2021 | 367 | 0.040 |
Why?
|
Reference Standards | 1 | 2021 | 1025 | 0.040 |
Why?
|
Health Expenditures | 1 | 2009 | 2349 | 0.040 |
Why?
|
Risk Assessment | 2 | 2009 | 23336 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2017 | 15535 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12244 | 0.040 |
Why?
|
Sex Factors | 1 | 2010 | 10400 | 0.040 |
Why?
|
Journal Impact Factor | 1 | 2018 | 156 | 0.030 |
Why?
|
Health Behavior | 1 | 2008 | 2635 | 0.030 |
Why?
|
Regression Analysis | 1 | 2006 | 6459 | 0.030 |
Why?
|
Urinalysis | 1 | 2017 | 369 | 0.030 |
Why?
|
Encyclopedias as Topic | 1 | 2014 | 20 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2021 | 2715 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2019 | 711 | 0.030 |
Why?
|
Diagnosis-Related Groups | 1 | 2015 | 455 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2020 | 3508 | 0.030 |
Why?
|
Primary Health Care | 1 | 2009 | 4557 | 0.030 |
Why?
|
Emergencies | 1 | 2019 | 1170 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14723 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2021 | 5077 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2011 | 20130 | 0.020 |
Why?
|
Physical Examination | 1 | 2017 | 1237 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2022 | 8642 | 0.020 |
Why?
|
Heart Diseases | 1 | 2003 | 2789 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2006 | 13991 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 20824 | 0.020 |
Why?
|
Critical Illness | 1 | 2022 | 2670 | 0.020 |
Why?
|
Medication Adherence | 1 | 2020 | 2063 | 0.020 |
Why?
|
Geography | 1 | 2010 | 669 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6194 | 0.020 |
Why?
|
Medicaid | 1 | 2021 | 2737 | 0.020 |
Why?
|
Random Allocation | 1 | 2012 | 2428 | 0.020 |
Why?
|
Patient Discharge | 1 | 2019 | 3318 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15078 | 0.020 |
Why?
|
Leukocytosis | 1 | 2006 | 247 | 0.020 |
Why?
|
Pneumonia | 1 | 2016 | 2133 | 0.020 |
Why?
|
Ultrasonography | 1 | 2017 | 5984 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5717 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 3086 | 0.010 |
Why?
|
Triage | 1 | 2005 | 977 | 0.010 |
Why?
|
Linear Models | 1 | 2005 | 5953 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 35425 | 0.000 |
Why?
|